Related Experiment Video

Updated: May 15, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

297

Obinutuzumab: a new frontier in the treatment of refractory idiopathic membranous nephropathy

Muhammad Umar Ahsan1, Arooj Tabassum2, Kinza Naseem2

  • 1D.G.Khan Medical College, Dera Ghazi Khan, Punjab, Pakistan. umarahsan219@gmail.com.

International Urology and Nephrology
|April 9, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Idiopathic membranous nephropathyObinutuzumabRefractory IMN

More Related Videos

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

5.3K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.2K

Related Experiment Videos

Last Updated: May 15, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

297
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

5.3K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness of Simulation-Based Training Versus Traditional Lecturing for Outbreak Investigation Among Medical Students: A Randomized Controlled Trial.

Journal of medical education and curricular development·2026

Isolated Abdominal Wall Endometriosis Presenting as an Anterior Abdominal Mass: Histopathological Confirmation.

Clinical case reports·2025

Atypical Retinitis Pigmentosa With Systemic Features in Bardet-Biedl Syndrome.

Clinical case reports·2025

Scalp Actinomycosis Presenting as Chronic Discharging Sinuses: A Rare Case Report.

Clinical case reports·2025

The EMS Swiss LithoClast® Trilogy for the treatment of large bladder stones: a prospective international multicenter study.

International urology and nephrology·2026

Indocyanine green (ICG) fluorescence for intraoperative identification of ileal conduits in robot-assisted surgery: a description of surgical technique.

International urology and nephrology·2026

Comparative analysis of international guidelines for the management of chronic kidney disease mineral and bone disorder.

International urology and nephrology·2026

In-hospital outcomes by peritoneal versus hemodialysis inpatient procedure coding in adults with end-stage kidney disease: a 2021 National Inpatient sample study.

International urology and nephrology·2026

Experiences of self-advocacy in patients with chronic kidney disease: a qualitative study.

International urology and nephrology·2026

Oral spray sildenafil in erectile dysfunction: current evidence and clinical perspectives.

International urology and nephrology·2026

Frequency of Bloodwork in Patients on Immune Checkpoint Inhibitors.

Current oncology (Toronto, Ont.)·2026

Immunotherapy in Liver Transplant Recipients with Advanced Solid Malignancies: A Three-Patient Case Series.

Current oncology (Toronto, Ont.)·2026

Cancer Immunotherapy and Immune-Related Adverse Events: Focusing on Non-Small Cell Lung Cancer.

Current oncology (Toronto, Ont.)·2026

Cell-Based Assay Development and Standardization for Antibody-Drug Conjugates.

Biotech (Basel (Switzerland))·2026

Switching Beyond Rituximab in Primary Glomerular Diseases: A Systematic Review of Within-Patient Efficacy and Safety of Non-Rituximab Anti-CD20 Antibodies.

Antibodies (Basel, Switzerland)·2026

Molecular Characterisation of the Nuclear Localisation Sequence Binding Properties of Toxoplasma gondii Importin α.

Cells·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us